Castle Biosciences Stock Price on September 10, 2024
| CSTL Stock | USD 30.28 0.16 0.53% |
Below is the normalized historical share price chart for Castle Biosciences extending back to July 25, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Castle Biosciences stands at 30.28, as last reported on the 29th of November, with the highest price reaching 30.80 and the lowest price hitting 29.85 during the day.
If you're considering investing in Castle Stock, it is important to understand the factors that can impact its price. As of now, Castle Stock is very steady. Castle Biosciences secures Sharpe Ratio (or Efficiency) of 0.0337, which signifies that the company had a 0.0337% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Castle Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Castle Biosciences' Risk Adjusted Performance of 0.0317, mean deviation of 2.38, and Downside Deviation of 2.85 to double-check if the risk estimate we provide is consistent with the expected return of 0.11%.
At this time, Castle Biosciences' Common Stock Total Equity is quite stable compared to the past year. Stock Based Compensation is expected to rise to about 53.8 M this year, although the value of Common Stock Shares Outstanding will most likely fall to about 19.8 M. . At this time, Castle Biosciences' Price Book Value Ratio is quite stable compared to the past year. Price Earnings To Growth Ratio is expected to rise to 0.62 this year, although the value of Price Earnings Ratio will most likely fall to (10.57). Castle Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of July 2019 | 200 Day MA 25.0993 | 50 Day MA 30.9432 | Beta 0.985 |
Castle |
Sharpe Ratio = 0.0337
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | CSTL | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.23 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Castle Biosciences is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Castle Biosciences by adding it to a well-diversified portfolio.
Price Book 1.933 | Enterprise Value Ebitda 23.9053 | Price Sales 2.7336 | Shares Float 27.2 M | Wall Street Target Price 41.5556 |
Related Headline
Sera Prognostics Headline on 10th of September 2024
Disposition of 25085 shares by Lindgardt Zhenya of Sera Prog... by Lindgardt Zhenya
Filed transaction by Sera Prognostics Director, Officer: Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Castle Biosciences Valuation on September 10, 2024
It is possible to determine the worth of Castle Biosciences on a given historical date. On September 10, 2024 Castle was worth 29.37 at the beginning of the trading date compared to the closed value of 29.3. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Castle Biosciences stock. Still, in general, we apply an absolute valuation method to find Castle Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Castle Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Castle Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 29.39 | 29.71 | 29.22 | 29.33 | 164,725 | |
09/10/2024 | 29.37 | 29.52 | 28.56 | 29.30 | 189,996 |
| 29.16 | 31.16 | 28.76 | 31.03 | 372,324 |
| Backtest Castle Biosciences | | | Castle Biosciences History | | | Castle Biosciences Valuation | Previous | Next |
Castle Biosciences Trading Date Momentum on September 10, 2024
| On September 11 2024 Castle Biosciences was traded for 31.03 at the closing time. The top price for the day was 31.16 and the lowest listed price was 28.76 . The trading volume for the day was 372.3 K. The trading history from September 11, 2024 was a factor to the next trading day price upswing. The overall trading delta against the next closing price was 5.90% . The overall trading delta against the current closing price is 4.37% . |
Castle Biosciences Fundamentals Correlations and Trends
By evaluating Castle Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Castle Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Castle financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Castle Biosciences Stock history
Castle Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Castle is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Castle Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Castle Biosciences stock prices may prove useful in developing a viable investing in Castle Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.8 M | 19.8 M | |
| Net Loss | -60.4 M | -57.4 M |
Castle Biosciences Quarterly Net Working Capital |
|
Castle Biosciences Stock Technical Analysis
Castle Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Castle Biosciences Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Castle Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Castle Biosciences November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Castle Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Castle Biosciences shares will generate the highest return on investment. By undertsting and applying Castle Biosciences stock market strength indicators, traders can identify Castle Biosciences entry and exit signals to maximize returns
Castle Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Castle Biosciences' price direction in advance. Along with the technical and fundamental analysis of Castle Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Castle to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0317 | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0758 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share 0.21 | Revenue Per Share 11.34 | Quarterly Revenue Growth 0.395 | Return On Assets (0) |
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.